Elimination of the class a scavenger receptor does not affect amyloid plaque formation or neurodegeneration in transgenic mice expressing human amyloid protein precursors
F. Huang et al., Elimination of the class a scavenger receptor does not affect amyloid plaque formation or neurodegeneration in transgenic mice expressing human amyloid protein precursors, AM J PATH, 155(5), 1999, pp. 1741-1747
Citations number
49
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
The class A scavenger receptor (SR) is expressed on reactive microglia surr
ounding cerebral amyloid plaques in Alzheimer's disease (AD). Interactions
between the SR and amyloid beta peptides (A beta) in microglial cultures el
icit phagocytosis of A beta aggregates and release of neurotoxins. To asses
s the role of the SR in amyloid clearance and A beta-associated neurodegene
ration in vivo, we used the platelet-derived growth factor promoter to expr
ess human amyloid protein precursors (hAPPs) in neurons of transgenic mice.
With increasing age, hAPP mice develop AD-like amyloid plaques. We bred he
terozygous hAPP (hAPP(+/-)) mice that were wild type for SR (SR+/+) with SR
knockout (SR-/-) mice. Crosses among the resulting hAPP(+/-)SR(+/-) offspr
ing yielded hAPP(+/-) and hAPP(-/-) littermates that were SR+/+ or SR-/-. T
hese second-generation mice were analyzed at 6 and 12 months of age for ext
ent of cerebral amyloid deposition and loss of synaptophysin-immunoreactive
presynaptic terminals. hAPP(-/-)SR(-/-) mice showed no lack of SR expressi
on, plaque formation, or synaptic degeneration, indicating that lack of SR
expression does not result in significant accumulation of endogenous amyloi
dogenic or neurotoxic factors. In hAPP(+/-) mice, ablation of SR expression
did not alter number, extent, distribution, or age-dependent accumulation
of plaques; nor did it affect synaptic degeneration. Our results do not sup
port a critical pathogenic role for microglial SR expression in neurodegene
rative alterations associated with cerebral beta amyloidosis.